CHD · 10-Q · 2026Q3 · Full report
Capital Expenditures
CHURCH & DWIGHT CO INC /DE/ · 2026-10-30 · Importance 52 · Surprise 56 · Matches filing data
The company expects 2026 capital expenditures of approximately $125.0 million. Planned spending includes manufacturing-capacity investments for THERABREATH and Sterimar and an enterprise resource planning project. Property, plant, and equipment additions were $91.6 million in the first nine months of 2026, compared with $67.2 million in the prior-year period. Management expects operating cash and borrowing capacity to fund the capital program alongside debt service, dividends, and share repurchases as implemented.
Key facts
- The Company expects 2026 capital expenditures of approximately $125.0 million, including manufacturing-capacity investments for THERABREATH and Sterimar and an ERP project. source
- Net cash used in investing activities in the first nine months of 2026 was $402.7 million, including $300.0 million for Miss Mouth's, $91.6 million for property, plant and equipment additions, and $10.0 million for an acquisition-liability payment. source
- The Company spent $91.6 million on additions to property, plant and equipment in the first nine months of 2026, compared with $67.2 million in the same period of 2025. source
- The Company’s net PP&E was $834.8 million at September 30, 2026, compared with $822.8 million at December 31, 2025. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -1.0% | Net cash used in investing activities in the first nine months of 2026 was $402.7 million, including $300.0 million for Miss Mouth's,… |
| cash | negative | committed | -0.3% | The Company expects 2026 capital expenditures of approximately $125.0 million, including manufacturing-capacity investments for… |